Comparative effects of conventional hormone replacement therapy and tibolone on climacteric symptoms and sexual dysfunction in postmenopausal women

Climacteric

Volumn 13, Issue 2, 2010, Pages 147-156

  Ziaei, S ^a   Moghasemi, M ^a   Faghihzadeh, S ^a  

^a TARBIAT MODARES UNIVERSITY   (Iran)

Author keywords

Conjugated equine estrogen medroxyprogesterone acetate; Free estradiol index; Free testosterone index; Greene climacteric scale; Rosen's female sexual function index; Sex hormone binding globulin; Tibolone

Indexed keywords

CALCIUM; CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; ESTRADIOL; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; TIBOLONE; VITAMIN D;

ADULT; ANXIETY DISORDER; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRUG EFFICACY; DRUG WITHDRAWAL; DYSPAREUNIA; ESTRADIOL BLOOD LEVEL; FEMALE; FEMALE SEXUAL DYSFUNCTION; FOLLOW UP; FUNCTIONAL ASSESSMENT; HORMONAL THERAPY; HORMONE SUBSTITUTION; HOT FLUSH; HUMAN; LIBIDO; LIBIDO DISORDER; LUBRICATION; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; NIGHT SWEAT; ORGASM; ORGASM DISORDER; OUTCOME ASSESSMENT; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SEXUAL AROUSAL; SEXUAL AROUSAL DISORDER; SEXUAL FUNCTION; SEXUAL SATISFACTION; SOMATIZATION; TESTOSTERONE BLOOD LEVEL;

CLUSTER ANALYSIS; DRUG THERAPY, COMBINATION; ESTRADIOL; ESTROGEN RECEPTOR MODULATORS; ESTROGEN REPLACEMENT THERAPY; ESTROGENS, CONJUGATED (USP); FEMALE; HOT FLASHES; HUMANS; LIBIDO; MIDDLE AGED; NORPREGNENES; ORGASM; POSTMENOPAUSE; PROSPECTIVE STUDIES; SEXUAL BEHAVIOR; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; TESTOSTERONE; TREATMENT OUTCOME;

EID: 77249157331     PISSN: 13697137     EISSN: 14730804     Source Type: Journal    
DOI: 10.3109/13697130903009195     Document Type: Article

References (25)

1. Warren MP, Halpert S. Hormone replacement therapy controversies, pros and cons. Best Pract Res 2004;18:317-332
2. Somukiran A, Erel CT, Demirci F, Senturk ML. The effect of tibolone versus 17b-estradiol on climacteric symptoms in women with surgical menopause: a randomized, cross-over study. Maturitas 2007;56:61-68
3. Bjorn I, Backstrom T, Lalos A, Sundstrom- Poromaa I. Adverse mood effects during postmenopausal hormone treatment in relation to personality traits. Climacteric 2006;9:290-297
4. Bruhat M, Rudolf K, Vaheri R, Kainulainen P, Timonen V, Viitanen A. Effective bleeding control and symptom relief by lower dose regimens of continuous combined hormone replacement therapy. Maturitas 2001;40:259-271
5. Utian WH, Shoupe D, Bachmann G, Pinkerton JV, Pickar JH. Relief of vasomotor symptoms and vaginal atrophy with lower doses of conjugated equine estrogens and medroxyprogesterone acetate. Fertil Steril 2001;75:1065-1079
6. Larson B, Collins A, Landgren BM. Urogenital and vasomotor symptoms in relation to menopausal status and the use of hormone replacement therapy (HRT) in healthy women during transition to menopause. Maturitas 1997;28:99-105
7. Timmer CJ, Verheul HAM, Doorstam DP. Pharmacokinetics of tibolone in early and late postmenopausal women. Br J Clin Pharmacol 2002;54:101-106
8. Modelska K, Cummings S. Tibolone for postmenopausal women: systematic review of randomized trials. J Clin Endocrinol Metab 2001; 87:116-123
9. Greene JG. Constructing a standard climacteric scale. Maturitas 1998;29:25-31
10. Rosen R, Brown C, Heiman J, et al. The female sexual function index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther 2000;26:191-208
11. Derman RJ, Dawood MY, Stone S. Quality of life during sequential hormone replacement therapy: a placebo controlled study. Int J Fertil 1995;40:73-78
12. Ulrich LG, Barlow DH, Sturdee DW, et al. Quality of life and patient preference for sequential versus continuous combined HRT: the UK Kliofem multicenter study experience. Int J Gynecol Obstet 1997;59:11-17
13. Barentsen R, Van de Waijer PHM, Van Gend S, Foekema H. Climacteric symptoms in a representative Dutch population sample as measured with the Greene Climacteric Scale. Maturitas 2001;38:123-128
14. Lam PM, Cheung GWY, Shek DTL, Lee DTS, Haines CJ, Chung TKH. A randomized placebocontrolled, crossover study of tibolone (Livial) on menopause symptoms, psychological wellbeing, and dyadic relationship of postmenopausal Chinese women and their spouses. Menopause 2004;11:416-422
15. Liu JH. Therapeutic effects of progestins, androgens, and tibolone for menopausal symptoms. Am J Med 2005;118:88-92
16. Hammar M, Christau S, Nathorst-Boos J, Rud T, Garre K. A double-blind, randomized trial comparing the effects of tibolone and continuous combined hormone replacement therapy in postmenopausal women with menopausal symptoms. BJOG 1998;105:904-911
17. Huber J, Palacios S, Berglund L, et al. Effects of tibolone and continuous combined hormone replacement therapy on bleeding rates, quality of life and tolerability in postmenopausal women. BJOG 2002;109:886-893
18. Mathur RS, Landgreve SC, Moody LO, Semmens JP, Williamson HO. The effect of estrogen treatment on plasma concentrations of steroid hormones, gonadotropins, prolactin and sex hormone binding globulin in postmenopausal women. Maturitas 1985;7:129-133
19. Cayan F, Dilek U, Pata O, Dilek S. Comparison of the effects of hormone therapy regimens, oral and vaginal estradiol, estradiol + drospirenone and tibolone, on sexual function in healthy postmenopausal women. J Sex Med 2008;5: 132-138
20. Nijland EA, Weijmar Schultz WCM, Nathorst- Boos J, et al. Tibolone and transdermal E2/ NETA for the treatment of female sexual function in naturally menopausal women: results of a randomized active-controlled trial. J Sex Med 2008;5:646-656
21. Osmanagaoglu MA, Atasaral T, Baltaci O, Bozkaya H. Effect of different preparations of hormone therapy on sexual dysfunction in naturally postmenopausal women. Climacteric 2006;9:464-472
22. Kokcu A, Cetinkaya MB, Yanik F, Alper T, Malatyalioglu E. The comparison of effects of tibolone and conjugated estrogen medroxyprogesterone acetate therapy on sexual performance in postmenopausal women. Maturitas 2000;36: 75-80
23. Egarter C, Topcuoglu A, Vogl S, Sator M. Hormone replacement therapy with tibolone: effects on sexual functioning in postmenopausal women. Acta Obstet Gynecol Scand 2002;81: 649-653
24. Kloosterboer HJ. Tibolone: a steroid with a tissue-specific mode of action. J Steroid Biochem Mol Biol 2001;76:231-238
25. Palacios S, Tobar AC, Menendez C. Sexuality in the climacteric years. Maturitas 2002;43:S69-77